High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy
Jung Eun Lee, Ji Hee Lim, Yong Kil Hong, Seung Ho Yang
Cancer Res Treat. 2018;50(4):1331-1342.   Published online 2018 Jan 10     DOI: https://doi.org/10.4143/crt.2017.466
Citations to this article as recorded by Crossref logo
GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status
Isabele Fattori Moretti, Antonio Marcondes Lerario, Paula Rodrigues Sola, Janaína Macedo-da-Silva, Mauricio da Silva Baptista, Giuseppe Palmisano, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie
Cancers.2023; 15(3): 587.     CrossRef
Fatimah Haitham Fathi, Ammar A. Y. Almulathanon, Jehan A. Mohammad
Military Medical Science Letters.2022; 91(4): 348.     CrossRef
Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
Haksoo Lee, Dahye Kim, BuHyun Youn
International Journal of Molecular Sciences.2022; 23(22): 13818.     CrossRef
Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway
Jinbiao Xiong, Gaochao Guo, Lianmei Guo, Zengguang Wang, Zhijuan Chen, Yang Nan, Yiyao Cao, Ruilong Li, Xuejun Yang, Jun Dong, Xun Jin, Weidong Yang, Qiang Huang
ACS Omega.2021; 6(6): 4289.     CrossRef
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
Silvia Valtorta, Alessia Lo Dico, Isabella Raccagni, Cristina Martelli, Valentina Pieri, Paolo Rainone, Sergio Todde, Bastian Zinnhardt, Elisabetta De Bernardi, Angela Coliva, Letterio S. Politi, Thomas Viel, Andreas H. Jacobs, Rossella Galli, Luisa Ottob
Frontiers in Oncology.2021;[Epub]     CrossRef
Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook
Kevin Zhai, Manaal Siddiqui, Basma Abdellatif, Alena Liskova, Peter Kubatka, Dietrich Büsselberg
Cancers.2021; 13(10): 2317.     CrossRef
Role of Polymeric Local Drug Delivery in Multimodal Treatment of Malignant Glioma: A Review
Yuan-Yun Tseng, Tai-Yuan Chen, Shih-Jung Liu
International Journal of Nanomedicine.2021; Volume 16: 4597.     CrossRef
In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma
Vikas Soni, Manish Adhikari, Hayk Simonyan, Li Lin, Jonathan H. Sherman, Colin N. Young, Michael Keidar
Cancers.2021; 13(17): 4485.     CrossRef
Landscape of the oncogenic role of fatty acid synthase in human tumors
Xulei Huo, Lairong Song, Da Li, Ke Wang, Yali Wang, Feng Chen, Liwei Zhang, Liang Wang, Junting Zhang, Zhen Wu
Aging.2021; 13(23): 25106.     CrossRef
Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer
Sonia A. Allen, Sandipan Datta, Jose Sandoval, Alexey Tomilov, Thomas Sears, Kevin Woolard, James M. Angelastro, Gino A. Cortopassi
Mitochondrion.2020; 50: 19.     CrossRef
Metformin treatment decreases the expression of cancer stem cell marker CD44 and stemness related gene expression in primary oral cancer cells
Shankargouda Patil
Archives of Oral Biology.2020; 113: 104710.     CrossRef
Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep- 2 to 5-Fluorouracil
Neslisah Barlak, Fatma Sanli, Ozel Capik, Elanur Tuysuz, Elanur Aydın Karatas, Hasan Turkez, Omer Faruk Karatas
Clinical Cancer Drugs.2020; 7(1): 16.     CrossRef
An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin
Marta Calvo Tardón, Eliana Marinari, Denis Migliorini, Viviane Bes, Stoyan Tankov, Emily Charrier, Thomas A McKee, Valérie Dutoit, Pierre-Yves Dietrich, Erika Cosset, Paul R Walker
Biology.2020; 9(9): 264.     CrossRef
Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
Rashmi R. Shah, Peter D. Stonier
Journal of Clinical Pharmacy and Therapeutics.2019; 44(1): 6.     CrossRef
Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity
Federica Barbieri, Ivan Verduci, Valentina Carlini, Gianluigi Zona, Aldo Pagano, Michele Mazzanti, Tullio Florio
Frontiers in Oncology.2019;[Epub]     CrossRef
DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy
Yosef Masoudi-Sobhanzadeh, Yadollah Omidi, Massoud Amanlou, Ali Masoudi-Nejad
Computers in Biology and Medicine.2019; 109: 254.     CrossRef
Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells
Alessia Lo Dico, Silvia Valtorta, Luisa Ottobrini, Rosa Maria Moresco
Frontiers in Oncology.2019;[Epub]     CrossRef
Repurposing drugs for the treatment of glioma
Chengming Xu, Yaodong Zhao, Congyan Wu, Lei Li
Glioma.2019; 2(4): 159.     CrossRef
Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway
Chung-Ching Chio, Yu-Ting Tai, Mahendravarman Mohanraj, Shing-Hwa Liu, Shun-Tai Yang, Ruei-Ming Chen
Phytomedicine.2018; 49: 41.     CrossRef
Pleiotropic Effects of Metformin on Cancer
Hans-Juergen Schulten
International Journal of Molecular Sciences.2018; 19(10): 2850.     CrossRef
Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway
Chu Zhang, Yuchen Wang
Molecular Medicine Reports.2018;[Epub]     CrossRef